See this page online at: http://www.bioscienceworld.ca/Profiles
Sign up for your subscription and keep up-to-date.
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
|
April 06 2011
Canada Gairdner Award recipients unveiled The Gairdner Foundation has announced the recipients of the 2011 Canada Gairdner Awards.
|
|
February 22 2011
NSERC announces winners of Canada’s top science prizes The Natural Sciences and Engineering Research Council of Canada (NSERC) has announced the winners of Canada's top natural sciences and engineering prizes awarded by NSERC.
|
|
February 22 2011
Fathers of stem cell research honoured on 50th anniversary of groundbreaking discovery February marks the Fiftieth anniversary of the landmark discovery where two young unknown scientists at the fledgling Ontario Cancer Institute (OCI) first published accidental findings that proved the existence of stem cells - cells that can self-renew repeatedly for different uses.
|
|
February 17 2011
Angiotech Pharmaceuticals delisted from NASDAQ Trading of shares of Angiotech Pharmaceuticals, Inc. common stock has been transferred from the Nasdaq Stock Market to the OTCQB™ Marketplace effective January 13, 2011.
|
|
February 17 2011
Bioniche completes Australian offer, raising $12.5 Million Canadian biopharmaceutical company Bioniche Life Sciences Inc. has successfully completed its Australian Offer of 8.6 million CHESS Depositary Instruments (CDIs) at A$1.45 per CDI, raising gross proceeds of A$12.5 million.
|
|
January 24 2011
Key executive in BC life sciences joins Genome BC team Dr. Alan Winter, president and CEO of Genome British Columbia announces the appointment of Dr. Brad Popovich as chief scientific officer for Genome British Columbia.
|
|
November 22 2010
Trent University professor named Fellow of the Royal Canadian Geographical Society Trent alumnus and professor in the Department of Geography Dr. Peter Lafleur was named a fellow of the Royal Canadian Geographical Society (RCGS) at a fellows dinner in Ottawa, for his research on climate change, particularly in the North and service to the Society.
|
|
September 16 2010
Genome Canada chair elected to the Royal Society of Canada Dr. C. Thomas Caskey, M.D., chair of the Board of Genome Canada and prominent medical geneticist and biomedical entrepreneur has been elected to the Division of Life Sciences of the Academy of Science of the Royal Society of Canada.
|
|
September 14 2010
Royal Society of Canada recognizes SFU biologist Bernard Crespi, renowned globally for his experimental and theoretical contributions to evolutionary biology...
|
|
July 15 2010
Genome Canada appoints new chair of its Science and Industry Advisory Committee Genome Canada appoints Dr. Jacques Simard (Ph.D.) as chair of Genome Canada's Science and Industry Advisory Committee, effective immediately.
|
|
July 07 2010
Aubrey J. Tingle Prize Presented to Dr. Julio Montaner BC Centre for Excellence in HIV/AIDS clinical director Dr. Julio Montaner is the first recipient of the Aubrey J. Tingle Prize, created in honour of the founding president and CEO of the Michael Smith Foundation for Health Research (MSFHR).
|
|
June 03 2010
BC biotech CEO recognized for innovative technology Ondine Biopharma CEO Carolyn Cross has been nominated for a 2010 Manning Innovation Award for her work in developing a photodisinfection technology, which uses light wavelengths to activate drugs that destroy bacteria, fungi and viruses without contributing to antibiotic resistance.
|
|
June 03 2010
Ontario honours its top innovators Each year the Premier’s Innovation Awards, part of Ontario’s Innovation Agenda, invests $200,000 to $5 million in the provinces top innovators to help advance their cutting-edge research and development, while boosting global competitiveness and creating more high-skilled jobs. This year’s awards ceremony, hosted by the Ontario Centre of Excellence (OCE) in partnership with MaRS institute, was held at the Metro Toronto Convention Centre following OCE’s fifth annual Discovery trade show and conference.
|
|
May 17 2010
Dr. Paul Lasko appointed scientific director of CIHR's Institute of Genetics Dr. Alain Beaudet, president of the Canadian Institutes of Health Research (CIHR), along with CIHR's Governing Council, announces the appointment of Dr. Paul Lasko as Scientific Director of CIHR's Institute of Genetics.
|
|
April 21 2010
Viterra announces strong first-quarter numbers Thanks to the acquisition of ABB Grain Ltd. (ABB) of Australia in September 2009, Viterra saw its consolidated sales and other operating revenues for the first quarter of fiscal 2010 grow $404.0 million to $1.8 billion.
|
|
March 26 2010
Canadian innovation to shine at 2010 "Davos of social entrepreneurship" MaRS CEO Dr. Ilse Treurnicht has been invited to speak at the Skoll World Forum in Oxford, UK. She will discuss the MaRS model of integrating social innovation alongside science and technology innovation.
|
|
March 23 2010
Eight Canadian scientists and scholars garner over $1 million in Killam Research Fellowships Eight outstanding Canadian researchers have been awarded a total of $1.12 million in the 43rd annual competition for Killam Research Fellowships, administered by the Canada Council for the Arts. The Fellowships provide $70,000 a year for two years to each of the researchers.
|
|
January 26 2010
Guelph teacher awarded third annual OGI genomics teaching prize The Ontario Genomics Institute (OGI) has awarded its 2009 Genomics Teaching Prize to Doug Gajic from Centennial Collegiate Vocational Institute (CVI) in Guelph, ON.
|
|
December 04 2009
Microbiologist among Canada’s 100 ‘most powerful women’ Simon Fraser University microbiologist Fiona Brinkman has been named to the 2009 top 100 list of Canada's Most Powerful Women by the Women’s Executive Network, a Toronto-based professional development agency.
|
|
December 03 2009
BioContact shows off the best kept secret in Canadian biotech: Quebec City According to the Genetic Engineering & Biotechnology News, in addition to being a historical city recognised by Unesco and an internationally acclaimed tourist destination for it’s European flavour, Quebec City is the best kept secret of the entire Canadian life science and biotechnology industry.
|
|
December 03 2009
OncoGenex Pharmaceuticals CEO wins Ernst & Young award in the health sciences category Scott Cormack, president and chief executive officer of OncoGenex, has been named Canada’s Pacific Ernst & Young Entrepreneur Of The Year®.
|
|
December 03 2009
Radient Technologies relocates operations to Edmonton Radient Technologies Inc. has chosen Edmonton AB to centralize its operations and expand production.
|
|
December 03 2009
Appointments Medicago Inc. announces the appointment of Pierre Marc Johnson, attorney, physician and former Premier of Quebec, to its board of directors.
|
|
December 03 2009
Career Spotlight Compiled by BioTalent Canada
|
|
November 25 2009
Canada’s first research chair in cardiovascular disease chosen Renowned B.C. kinesiologist and heart disease researcher Dr. Scott Lear is the inaugural recipient of the Pfizer/Heart and Stroke Foundation Chair in Cardiovascular Disease Prevention Research at St. Paul's Hospital, established in partnership with Simon Fraser University (SFU).
|
|
November 06 2009
Pfizer Canada announces Canadian cardiovascular research award recipients Pfizer Canada announces the sixth round of winners from its cardiovascular research awards program. Award recipients were announced at the Canadian Cardiovascular Congress in Edmonton, AB.
|
|
October 19 2009
Research icon and Nobel Laureate Dies at 95 Norman Borlaug, an American geneticist and Nobel Laureate has died at the age of 95. His work on wheat genetics, directly affected an estimated billion people in the middle-east, an accomplishment that earned him the Nobel Peace Prize in 1970.
|
|
September 25 2009
BDC Venture Capital wins CVCA 2009 deal of the year award for its investment in ViroChem Pharma The Business Development Bank of Canada (BDC), Caisse de dépôt et placement du Québec and Solidarity Fund QFL has received the Canadian Venture Capital & Private Equity Association 2009 Deal of the Year Award for the venture capital category. The co-investors received this recognition for their investment in ViroChem Pharma.
|
|
September 10 2009
Genome Prairie appoints Dr. Karen Chad to its board Genome Prairie announces that Dr. Karen Chad will be joining the board of directors at Genome Prairie.
|
|
September 10 2009
Generex names new chief scientific advisor Generex Biotechnology Corp has named Joseph Rubinfeld, one of the original founders of Amgen, Inc., as its new chief scientific advisor.
|
|
September 10 2009
Chamberlain announces transition at DALSA Corp. Savvas Chamberlain announces he will no longer be serving as DALSA Corporation’s chief technology officer. After his term ends October 12, 2009, Chamberlain will transition to his new non-managerial role as chairman.
|
|
September 10 2009
Researcher’s Dr. Michael Hayden & Dr. Robert Hancock receive Order of British Columbia By: LifeSciences British Columbia
Dr. Michael Hayden and Dr. Robert Hancock are among 13 individuals who have been awarded British Columbia's highest honour; the Order of B.C. |
|
August 28 2009
Calgary innovator gives surgeons a helping hand Calgary biomed engineer Brent King is the winner of a $10,000 Manning Innovation Award for inventing a unique device that accurately and securely positions a surgical patient's limb.
|
|
July 20 2009
Sunnybrook trauma program founder to receive the Order of Canada Canada’s Governor General Michaelle Jean announces the appointment of Dr. Marvin Tile as a Member of the Order of Canada for his contributions as a clinical orthopaedic surgeon, teacher, and groundbreaking researcher.
|
|
May 19 2009
Canadian Government Invites 17 Canadian Universities To Compete For Prestigious Canada Excellence Research Chairs The Honourable Tony Clement, Minister of Industry has revealed the winners of the first phase of the inaugural competition for the Canada Excellence Research Chairs (CERC) program.
|
|
May 19 2009
Career Spotlight Compiled by BioTalent Canada
Position: Clinical Research Assistant Name: Karen Waller Company: Global IQ Salary Range: $30,000 to $50,000 per year |
|
August 26 2008
Report contends weak worker skills threaten sustainability of Canada's Bio Clusters The biotech sector in Canada has grown 77% since 1988, but the lack of skilled employees might hamper its growth potential, according to a report by BioTalent Canada
|
|
August 12 2008
Outstanding Canadian innovators inducted into the Canadian Science and Engineering Hall of Fame Two scientists join 40 scientists and innovators recognized in the Canadian Science and Engineering Hall of Fame. This year's inductees are geneticist Louis Siminovitch and physicist Richard E. Taylor.
|
|
December 04 2007
Field of Beams Collaboration and co-operation among academic, government and industry partners is at the core of Saskatchewan’s growing life science industry.
|
|
December 04 2007
Creating a Commercialization Engine for Molecular Diagnostics Like snow flakes, no two people in
the world are exactly alike with the same genetic makeup. |
|
September 05 2007
Alberta - a home to innovation and entrepreneurial spirit By Alberta Advanced Education and Technology and Tonya Costoff
Alberta Innovation Well known for its beautiful Rocky Mountains, its booming oil and gas industry and its entrepreneurial spirit, Alberta is also known for its strong advanced learning system, innovation and scientific excellence. The Alberta government is serious about planning for the future – a future that anticipates the necessary post-secondary training to build a workforce capable of: further developing value-added industries; undertaking focused and targeted research in areas of strategic importance to the province and creativity and capacity to commercialize technology. |
|
April 18 2007
Developing innovative, safe and effective therapies By Tonya Costoff
Is What Keeps This Executive Focused Heading up a biopharmaceutical company is no easy task, it's full of challenges, risks and plenty of bumps along the way, but Hans J. Mäder, president and CEO of Ambrilia Biopharma Inc., wouldn't have it any other way. |
|
March 12 2007
Biotec A Risky Business But Well Worth It You've heard it before - biotech is a risky business to get into. It costs a lot of money, it's a long process getting a drug to the marketplace and there's never a guarantee at the end of it all that you'll make a profit.
|
|
January 10 2007
Getting To The Point Of Success Through Passion And Patience By Tonya Costoff Passion and patience is what got Dr. T. Nathan Yoganathan where he is today. And just where that is, is the president and chief scientific officer of Med BioGene (MBI), a biotechnology company that is revolutionizing the diagnosis and treatment of certain cancers and cardiovascular disease by identifying the genes known as 'biomarkers', that indicate the presence of such diseases.
|
|
November 27 2006
Ottawa council unveils Canada's top 10 finalists Winning a national award: gratifying. Being able to present that winning concept to an audience of venture capitalists and potential strategic partners: priceless.
|
|
November 27 2006
The Toronto Biotechnology Initiative names new executive director The Toronto Biotechnology Initiative (TBI) announces the appointment of a new executive director, Bill Laidlaw.
|
|
November 27 2006
Canadian biotech among fastest sectors Thirteen Canadian biotechnology companies were among the Deloitte Fast 500, an annual award program ranking the fastest growing technology, media and telecommunications companies based on five year average revenue growth (2001-2005).
|
|
November 07 2006
RBC names new VP Joe Olivier has been appointed Vice-President, Commercial Financial Services for Knowledge Based Industries, Ontario, for RBC Royal Bank.
|
|
November 02 2006
Sunnybrook Expands Emergency And Trauma Centre Sunnybrook Health Sciences Centre broke ground in September on an expanded emergency department (ED) and regional trauma centre.
|
|
November 02 2006
Sanofi Expansion For Single Shot Children alarmed by the sight of a needle might not appreciate the significance just yet, but Sanofi Pasteur announced in September a $30 million capital expansion project to its manufacturing site in Toronto, where it produces combination vaccines that require only one needle.
|
|
November 01 2006
New name in genomics As of October, ChondroGene Ltd. has changed its name to GeneNews Ltd.
|
|
October 24 2006
Young biotech entrepreneur honoured The founder of a successful Prince Edward Island firm producing bioactive animal feed has been among the recipients of an award celebrating his success.
|
|
October 03 2006
Westin To Head Medicure Clinical Development Jan-Ake Westin has been appointed vice-president of Clinical Development for Medicure Inc.
|
|
October 02 2006
Sanofi pasteur to expand Toronto production of new vaccine technology Toronto Region Research Alliance (TRAA) has applauded the decision by Sanofi Pasteur to expand its Connaught Campus to increase its manufacturing capacity of vaccines. The vaccine company currently supplies combination vaccines requiring only one needle to 52 countries around the world.
|
|
September 13 2006
SFU Grad Awarded Top Doctoral Prize Yonghong Bing, PhD, a 2005 doctoral graduate at Simon Fraser University is the recipient of a 2006 Natural Sciences and Engineering Research Council of Canada Doctoral Prize.
|
|
September 11 2006
The Transition Year Transition Therapeutics Inc. isn't a company that sits back and lets things happen. This Toronto-based biopharmaceutical firm is all about action.
|
|
September 08 2006
Eisenhauer Wins Presidency Dr. Elizabeth Eisenhauer, an internationally recognized oncologist, has been appointed president of the National Cancer Institute of Canada.
|
|
August 29 2006
Monsanto Canada Appoints VP, GM Winnipeg-based Monsanto Canada has appointed Sean Gardner as its new vice-president and general manager of Canadian business operations.
|
|
August 10 2006
Northern Exposure Urigen Holdings relocates from California to Vancouver to pursue treatments for urological indications |
|
August 09 2006
Gene Hunter Bags Top National Award Dr. Robert Hegele, known as London, Ont.s gene hunter, recently received the Genetics Society of Canadas top national award.
|
|
August 02 2006
Pheromone Sciences Establishes Business Advisory Board Kelowna, B.C. based Pheromone Sciences Corp. has established a business advisory board to guide the commercialization process for the companys diabetes product.
|
|
July 05 2006
Canadian Chair in Hypertension Appointed Dr. Norm Campbell will serve as the first Canadian Chair in Hypertension Prevention and Control.
|
|
July 05 2006
Thermo Appoints Canadian GM Thermo Electron Corp. (Waltham, MA) has appointed Murray Wigmore as the general manager for the Scientific Instruments division in Canada.
|
|
July 05 2006
AnorMED CEO and President Steps Down With an eye to the future, Michael Abrams, PhD has resigned as president and CEO of AnorMED Inc. (Vancouver, BC) posts he has held since founding the company in 1996.
|
|
May 31 2006
Nobel Laureate Joins UBC UBC is benefiting from the experience and know-how of Nobel Laureate and recent addition to its staff, Carl E. Wieman, PhD.
|
|
May 31 2006
UBC Pioneer Wins Herzberg Medal David Dolphin, PhD, creator of one of the world's most successful eye disease treatments, has been honoured with the 2005 Gerhard Herzberg Canada Gold Medal for Science and Engineering.
|
|
March 13 2006
Janzen Appointed Cardiome President Doug Janzen has been named president and chief business officer of Vancouver-based Cardiome Pharma Corp.
|
|
March 02 2006
Ministry of Research and Innovation Names New DM Ontario Premier Dalton McGuinty has announced the appointment of Alastair Glass, PhD as deputy minister of the provinces Ministry of Research and Innovation.
|
|
March 02 2006
AEterna Regains Cetrorelix Rights, Appoints Board Member AEterna Zentaris Inc. (Quebec City, QC) has regained exclusive worldwide rights (excluding Japan) to cetrorelix, the company's luteinizing hormone releasing hormone (LHRH) antagonist product candidate, through a deal signed with Solvay Pharmaceuticals (Brussels, Belgium).
|
|
March 02 2006
Millenium Appoints Board Chairman Kingston, Ont.-based Millenium Biologix Corp. has appointed Brian S.G. Fielding as executive deputy chairman of its board of directors.
|
|
February 27 2006
AnorMED CEO Wins SCI Award Michael Abrams, PhD, president and CEO of Vancouver-based AnorMED Inc., been awarded the 2006 Julia Levy Award, presented by SCI Canada (London, UK).
|
|
February 06 2006
Cresswell, Stiller Named to Vasogen Board Mississauga, Ont.-based Vasogen Inc. has named Ronald Cresswell, PhD and Dr. Calvin Stiller to its board of directors.
|
|
February 06 2006
Chronogen Appoints New R&D VP Jean-Marie Houle, PhD has been named vice-president of research and development with Montreal-based biopharmaceutical company Chronogen Inc.
|
|
October 25 2005
Response Biomedical Expands RAMP Portfolio Response Biomedical Corp. (Burnaby, BC) has initiated commercialization of a new rapid detection test in its RAMP® line designed to detect strains of influenza A (flu A), including the Avian flu.
|
|
October 18 2005
Timely Challenge By Deborah Komlos Siegfried Hekimi, PhD embraced an opportune set of circumstances to establish Chronogen
|
|
September 20 2005
ProMetic a Finalist in Deloitte Fast 50 Program Montreal, Que.-based biopharmaceutical firm ProMetic Life Sciences Inc. has been named a finalist in Deloitte Fast 50 program, which recognizes the 50 fastest growing Canadian companies over a five-year period.
|
|
September 13 2005
Artisan of Change By Amber Lepage-Monette President and CEO Gilles Gagnon directs Aeterna Zentaris in its latest incarnation
|
|
July 05 2005
Allon Director Resigns Isaac Kohlberg, a founding director at Vancouver, B.C.-based Allon Therapeutics Inc., has resigned from the firm's board of directors.
|
|
June 20 2005
Viventia Establishes New Clinical Advisory Board Toronto, Ont.-based Viventia Biotech Inc. has announced the creation of its Head and Neck Cancer Clinical Advisory Board, designed to help the company develop late-stage clinical trials for its lead product, Proxinium(tm).
|
|
June 13 2005
ONTARIO - The Gateway to Success by Kristine Archer Ontario is poised to become a major global player in the biotech sector
|
|
May 17 2005
Biogen Idec Expands Mississauga Facility Biogen Idec Canada Inc., a subsidiary of Cambridge, Mass.-based biotechnology company Biogen Idec Inc., recently celebrated the expansion of its Mississauaga, Ont. offices.
|
|
May 10 2005
Intrinsic Drive By Deborah Komlos Lorus's Jim A. Wright, PhD has translated his passion for research into tangible therapeutic and corporate results
|
|
May 10 2005
United Front By Amber Lepage-Monette A proposed health research council could bring Ontario more funding, and unify a diverse community.
|
|
May 03 2005
Stressgen Announces Corporate Restructuring Victoria, B.C.-based Stressgen Biotechnologies Corp. has announced plans for a corporate restructuring designed to allow the company to focus solely on its lead drug candidate for human papillomavirus-related disease, HspE7.
|
|
April 19 2005
Millenia Hope Launches Asian Subsidiary Westmount, Que.-based Millenia Hope Inc. has announced plans to open a wholly owned subsidiary in Hong Kong.
|
|
April 12 2005
Natural Leader By Kristine Archer Jacqueline Shan, PhD discusses her successful journey with CV Technologies Inc.
|
|
April 12 2005
Provincial Power By Amber Lepage-Monette Health research organizations better position researchers for success
|
|
April 12 2005
EXCLUSIVE SPOTLIGHT: Ontario's New Biotech Voice By Deborah Komlos The BCO aims to be the public policy catalyst for growth
|
|
March 07 2005
Lifetime of Leadership By Amber Lepage-Monette Dr. Henry Friesen Discusses His Past and the Future of Canadian Health Care
|
|
February 28 2005
PricewaterhouseCoopers Creates New Pharma R&D Practice PricewaterhouseCoopers LLP (New York, NY) has announced the establishment of a new specialized pharmaceutical R&D operations practice.
|
|
January 13 2005
Top 10 Hits BioNorth's 11th By Tim Lougheed Everyone loves a top 10 list, and participants in Canada's international biotechnology and life sciences conference and exhibition are no exception. BioNorth is now in its 11th year, and for many people one of the highlights is the annual finalist list of Canadas Top 10 Life Science Companies, which was introduced in 1999.
|
|
January 04 2005
Head of the Class by Amber Lepage-Monette Focused graduate education aims to fill the skills gap in biotech
|
|
October 16 2004
Clinical Advisory Board Appointed at Aegera Cancer therapeutic company Aegera Therapeutics Inc. (Montreal, QC) has recently established its clinical advisory board.
|
|
September 13 2004
New CFO at Cangene Cangene Corp., a Winnipeg, Man.-based biotech company that produces plasma-derived and recombinant therapeutic proteins, has appointed Michael Graham as its new chief financial officer.
|
|
September 07 2004
Ecopia Awarded Prix Galien Canada The Canadian award for excellence in pharmaceutical and biotechnology research has been granted to Ecopia BioSciences Inc. (St-Laurent, QC).
|
|
August 23 2004
Anticancer CRUSADER By Amber Lepage-Monette DR. DAVID YOUNG OF ARIUS RESEARCH INC. IS DETERMINED TO SUCCEED IN PERSONALIZED CANCER THERAPY
|
|
July 27 2004
BHRC Launches Job Site When someone working in the biotech industry needs a job, where can they look? Why, in the PetriDish of course!
|
|
July 19 2004
Impressive PRESENCE By Deborah Komlos NEUREKA IS EXPANDING HEALTH SCIENCES RESEARCH AND BIOTECH UP NORTH
|
|
July 19 2004
Keep on Growing By Amber Lepage-Monette PERFORMANCE PLANTS INC. PRESIDENT AND CEO DAVID DENNIS, PHD KEEPS HIS EYE ON WHAT'S IMPORTANT
|
|
July 12 2004
Angiotech Strengthens Orthopedics Franchise Angiotech Pharmaceuticals Inc. (Vancouver, BC) has agreed to acquire Los Gatos, Calif.-based NeuColl Inc., a privately held orthobiologics company with a platform of synthetic bone graft matrices.
|
|
July 05 2004
CardioComm Solutions Gets Excellence Award Victoria, B.C.-based CardioComm Solutions Inc. has received an award for excellence in software.
|
|
June 22 2004
Bellini Receives Ordre National du Québec Francesco Bellini, PhD, chairman and CEO of Neurochem Inc. (Laval, QC), has been appointed as officer of the Ordre national du Québec by Premier Jean Charest.
|
|
June 16 2004
A Worthwhile Gamble By Amber Lepage-Monette M&A CAN HELP CANADIAN BIOTECHS BEAT THE ODDS
|
|
June 07 2004
U of A Professor Honoured Antoine Noujaim, PhD, professor emeritus at the University of Alberta (Edmonton, AB), and founder and CEO of ViRexx Medical Corp. (Edmonton, AB), has been honoured with a lifetime achievement award from the Canadian Society for Pharmaceutical Sciences (CSPS) (Edmonton, AB).
|
|
May 14 2004
EXECUTIVE PROFILE McPherson's Perspective By Patricia Nicholson Biomira's CEO takes a long look at biotech
|
|
May 10 2004
Management Shuffle at MDS MDS Inc. (Toronto, ON) has announced changes to its executive management team, including the departure of Ian Lennox, group president and CEO of Pharmaceutical and Biotech Markets, and the creation of a Chief Operating Officer (COO) position.
|
|
March 16 2004
Boosting from Below Ground By Deborah Komlos For farmers, much more than just hope is riding on their seed - quite literally.
In preparation for planting, farmers load their seed with various substances such as chemical fertilizers, fungicides and pesticides to help generate a healthy and productive crop. |
|
March 16 2004
Team Player By Amber Lepage-Monette As busy as he is, it's hard to believe Dr. K. Wayne Marshall, PhD was excited about starting a company. But lo and behold, taking on a fourth job wasn't going to stop this orthopedic surgeon, professor and team surgeon from pursuing a career in business.
|
|
March 16 2004
Building from a Blueprint By Patricia Nicholson The Canadian Institutes of Health Research (CIHR) (Ottawa, ON) has released the strategic plan that will direct its activities over the next five years.
|
|
February 23 2004
International VC Fund Focuses on Life Science The VIMAC Milestone Medica Fund LP celebrated its launch last week in Toronto, Ont. The new $100-million life science venture capital fund is sponsored by VIMAC Ventures LLP (Boston, MA), Royal Bank of Canada (Toronto, ON) subsidiary RBC Technology Ventures, and BTG International Inc. (London, U.K.).
|
|
November 01 2003
Biotech's Best Bets BY AMBER LEPAGE-MONETTE The OLSC showcases its Top 10 investment and partnering prospects
|
|
October 01 2003
Building Blockbuster Potential BY PATRICIA NICHOLSON New life for old molecules
By tinkering with a familiar molecule, Isotechnika Inc. came up with a drug candidate with blockbuster potential: the immunosuppressant ISA247, a high-potency cyclosporine analogue. |
|
September 01 2003
Got Your Goat BY PATRICIA NICHOLSON Nexia Biotechnologies CEO Jeffrey Turner, PhD is working on something big
|
|
August 01 2003
Sprouting from Alfalfa By Deborah Komlos Eager for change, Louis-Philippe Vézina, PhD planted a firm and a future
Alfalfa has altered his life and provided an alternative approach to recombinant molecule production, and for Louis-Philippe Vézina, PhD there has been no looking back. |
|
August 01 2003
R&D Big Spenders By Patricia Nicholson Biotech leads the way in R&D investment
Research Infosource Inc. (Toronto, ON) has released its annual list of Canadas Top 100 Corporate R&D Spenders. |
|
May 01 2003
Making the Business Case By Deborah Komlos Functioning similarly to the cover letter and resumé that land a critical interview, an effective business plan can prove invaluable. Emphasizing a companys strengths, successes and strategies for future milestone achievement, the plan can paint a picture of credibility and determination. The result: attracting much-needed financing.
|
|
March 03 2003
Packing a (Fruit) Punch By Patricia Nicholson KGK Synergize pursues nutraceuticals
Fruit juices may offer more benefits than you can get from drinking a glass of OJ. For Najla Guthrie, president and CEO of KGK Synergize Inc., those benefits include building a biotech business as well as offering some promising health possibilities. |
|
February 01 2003
Making it Work BY PATRICIA NICHOLSON Good project management can help the bottom line
Science may be the heart of every biotech company, but it's not enough to tend to your technology. You've got to mind your business, too. Cultivating the talent to do that in-house may not be practical, but project management consultants offer help for hire. |
|
January 01 2003
Cancer Drug Ingenuity - New Source, New Drug, New Issue BY DEBORAH KOMLOS A small Canadian firm's journey from independent, successful startup to struggle for subsistence
|
